New sesquiterpene and flavone arabinofuranoside derivative from the leaves of Fissistigma bicolor.

A new muurolane-type sesquiterpene, a new flavone arabinofuranoside derivative, and other five known flavone arabinofuranoside derivatives were isolated from the leaves of Fissistigma bicolor (Annonaceae family). Their chemical structures were determined to be (1S,6R,7S)-muurola-4,10(14)-diene-15-ol (1), quercetin 3-O-ß-D-apiofuranosyl-(1→2)-α-L-arabinofuranoside (2), quercetin 3-O-α-L-rhamnopyranosyl-(1→2)-α-L-arabinofuranoside (3), quercetin 3-O-α-L-arabinofuranoside (4), kaempferol 3-O-ß-D-apiofuranosyl-(1→2)-α-L-arabinofuranoside (5), kaempferol 3-O-α-L-rhamnopyranosyl-(1→2)-α-L-arabinofuranoside (6), and kaempferol 3-O-α-L-arabinofuranoside (7) by analyses of HR-ESI-MS and NMR spectral data. Compounds 4 and 7 containing monosaccharide, arabinofuranoside, potentially inhibited NO productions in LPS activated RAW264.7 cells (IC50 13.4 ± 0.5 and 12.6 ± 0.4 µM) in compared to disaccharide derivatives (IC50 ranging from 58.9 ± 3.3 to 65.6 ± 3.8 µM).

Characterization and Drug Release Control Ability of Chitosan/Lovastatin Particles Coated by Alginate.

We report on the coating of chitosan/lovastatin particles with a liquid solution of alginate using a 3D printing technique. The prepared particles are characterized by Scanning Electronic Microscopy, Infrared Spectroscopy, Dynamic Light Scattering, Differential Scanning Calorimetry, and Ultraviolet-Visible Spectroscopy. Characterization results reveal that the coating of alginate makes a considerable difference in the structure, morphology, size distribution and zeta potential of the chitosan/lovastatin particles, and the size of the coated particles is increased after the coating. We also demonstrate the drug release ability of the chitosan/lovastatin particles in simulated gastric fluid and controlled in simulated intestinal fluid. Drug release study reveals that the drug release profile of the coated particles varies significantly with the pH of the solution and the coating process significantly reduces the rate of release of the drug. We also report that the bioavailability of lovastatin particles can be improved by coating with the biopolymer layers.

Characteristics and Morphology of Nanosilica Modified with Isopropyl Tri(dioctyl Phosphate) Titanate Coupling Agent.

In order to improve dispersiveness of nanosilica in polymer matrix, surface organo-modification of nanosilica is necessary. This work reveals silica nanoparticles modified by titanate coupling agent isopropyltri (dioctylphosphate) titanate (KR12) in toluene solvent. Effect of reaction temperature, reaction time and reactant ratio on grafting efficiency have been studied by Thermogravimetric Analysis (TGA). The obtained results exhibit the grafted percentage of titanate coupling agent KR-12 on the surface of nanosilica increased quickly from 4.97 to 13.11 wt.% as increasing the content of KR-12 from 5 to 15 wt.% and raise slower from 13.21 to 13.43 wt.% as content of KR-12 in the range of 30 to 45 wt.%, respectively. The KR-12 content and grafting reaction time affect significantly on the grafting efficiency while temperature of grafting reaction is negative to the grafting efficiency. The results of analysis related to Infrared Spectroscopy and Energy-Dispersive X-ray spectroscopy (EDS) displayed titanate coupling agent KR-12 have been covalently bonded to surface of the nanosilica. The Transmission Electron Microscopy (TEM) images and size distribution indicated that after organic modification, nanosilica particles had average size about 86 nm and the agglomeration of nanoparticles decreased significantly. The obtained results showed that surface treatment of nanosilica with titanate coupling agent KR-12 was successful.